Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The Trial The ATTAIN-MAINTAIN trial enrolled patients who had achieved substantial weight loss that had plateaued while taking weekly injectable GLP-1s in the SURMOUNT-5 trial
S2CID 4712203
Additionally, subscriber growth excluding contributions from its compounded GLP-1 solutions increased 40% year over year during the period
When injected directly into the bloodstream, it can potentially aid in improving metabolic rates, leading to increased energy production and, over time, weight reduction
We've returned our core business to subscriber growth, quickly positioned our Clinical business as the gold standard in weight health with the ability to scale as supply comes back and launched the next wave of enhancements to our product and program that will provide the foundation for a more engaging digital experience. WW International analyst ratings and price targets are at MarketBeat
Collectively, these findings support the therapeutic potential of GLP-1RAs for managing BBS
US$ 25.56
US$ 22.95
US$ 24.00
US$ 25.79
US$ 21.02
US$ 20.47
US$ 27.49
US$ 20.13
US$ 28.87
US$ 25.98
US$ 20.03
US$ 22.90
